Effective treatment of solar facial porokeratosis in one patient with topical atorvastatin/cholesterol cream-Reference-Cited by-同舟云学术

Effective treatment of solar facial porokeratosis in one patient with topical atorvastatin/cholesterol cream

Published:2024-04-29 Issue: Volume: Page:
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:

Author:

Peng Kexin¹^ORCID,Wong Wenghong¹,Yan Kexiang¹,Zhang Zhenghua¹^ORCID

Affiliation:

1. Department of Dermatology, Huashan Hospital, Fudan University, Shanghai Institute of Dermatology , Shanghai , People’s Republic of China

Abstract

We report a rare case of solar facial porokeratosis (SFP) treated topically with atorvastatin/cholesterol or cholesterol alone for 48 weeks. The patient reported no obvious skin irritation and was delighted with the outcome. This study supported the effectiveness of a pathogenesis-directed treatment for SFP. Moreover, we point out that topical statins combined with cholesterol might have a long-term benefit in the treatment of SFP.

Funder

National Natural Science Foundation of China

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/ced/advance-article-pdf/doi/10.1093/ced/llae156/58341549/llae156.pdf

Reference5 articles.

1. Solar facial porokeratosis;Sharquie;J Dermatol,2003

2. Genomic variations of the mevalonate pathway in porokeratosis;Zhang;Elife,2015

3. Safety and efficacy of topical lovastatin plus cholesterol cream vs topical lovastatin cream alone for the treatment of disseminated superficial actinic porokeratosis: a randomized clinical trial;Santa Lucia;JAMA Dermatol,2023

4. Topical cholesterol/lovastatin for the treatment of porokeratosis: a pathogenesis-directed therapy;Atzmony;J Am Acad Dermatol,2020

5. The lovastatin-treated rodent: a new model of barrier disruption and epidermal hyperplasia;Feingold;J Invest Dermatol,1991